Biosig awarded u.s. patent claims for its neuroclear™ subsidiary

Westport, ct, march 04, 2021 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced that the u.s. patent office had allowed a utility patent that its majority-owned subsidiary neuroclear technologies, inc. has exclusively licensed from the mayo foundation for medical education and research.
BSGM Ratings Summary
BSGM Quant Ranking